BriaCell 2024 SABCS Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire27minutes ago

BriaCell Provides Update to Its Board of Directors

GlobeNewswireNov 25 07:50 ET

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BenzingaNov 21 11:47 ET

Briacell Therapeutics Has Dosed The First Patient In Its Phase 1/2 Study To Evaluate The Safety And Efficacy Of Bria-OTS, Briacell's Personalized Next Generation Immunotherapy

BenzingaNov 21 07:51 ET

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswireNov 8 07:50 ET

10-K: FY2024 Annual Report

SECOct 29 13:23 ET · Announcements